STERIS appoints Esther Alegria to Board of Directors effective May 3, 2023

STERIS plc

Board size increased to ten members; Dr. Alegria, age 64, appointed immediately.
She is Founder & CEO of APIE Therapeutics; previously SVP Global Manufacturing at Biogen.
Prorated director fee of $74,220 payable in restricted stock units for remainder of 2022-23 term.
Also serves on AVID Bioservices (NASDAQ: CDMO) board and its audit and governance committees.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Esther Alegria

Director

STE · STERIS plc

Effective: 2023-05-03
Filed: May 3, 2023, 7:59 PM ET

The Board of Directors (the “Board”) of STERIS plc (the “Company”) increased its size from nine to ten members on May 3, 2023, and elected Dr. Esther Alegria to serve as a director effective as of that date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Esther Alegria was elected as Director at STERIS plc.

Action: elected
Role: Director

Exact text from the filing

The Board of Directors (the “Board”) of STERIS plc (the “Company”) increased its size from nine to ten members on May 3, 2023, and elected Dr. Esther Alegria to serve as a director effective as of that date.

View on SEC.gov

STERIS plc filing history →

Source: SEC EDGAR

accession 0001193125-23-134570

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.